4SC is a biopharmaceutical company developing small-molecule drugs that target key indications in cancer with unmet medical needs. Its current product pipeline includes two programs in clinical development: resminostat, an orally administered histone deacetylase (HDAC) inhibitor with a mechanism of action that represents a therapy for a spectrum of oncology indications, both in monotherapy and in combination with other anti-cancer drugs); and domatinostat, an orally administered histone deacetylase (HDAC) inhibitor with a mode of action that was designed to strengthen the body’s own anti-tumor immune response.
Revenue growth (FY, 2018 - FY, 2019), %
Gross profit (FY, 2019)
Gross profit margin (FY, 2019), %
Net income (FY, 2019)
EBIT (FY, 2019)
Market capitalization (21-Sept-2021)
Closing stock price (21-Sept-2021)
4SC revenue breakdown by business segment: 100.0% from Asia
4SC has 330 Twitter Followers. The number of followers has decreased 0.7% month over month and decreased 1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was 4SC founded?
4SC was founded in 1997.
Who are 4SC key executives?
4SC's key executives are Jason Loveridge, Frank Hermann and Susanne Danhauser-Riedl.
How many employees does 4SC have?
4SC has 46 employees.
What is 4SC revenue?
Latest 4SC annual revenue is €2.2 m.
What is 4SC revenue per employee?
Latest 4SC revenue per employee is €47.7 k.
Who are 4SC competitors?
Competitors of 4SC include Imago BioSciences, Italfarmaco and Achilles Therapeutics.
Where is 4SC headquarters?
4SC headquarters is located at Fraunhoferstraße 22, Planegg.
Where are 4SC offices?
4SC has an office in Planegg.
How many offices does 4SC have?
4SC has 1 office.
Receive alerts for 300+ data fields across thousands of companies